Tempus AI strikes $1.5B deal for Personalis, betting big on AI-powered cancer detection
Covered by 2 sources · 2 articles
2 outlets - including Yahoo and Cryptobriefing - are covering this story. Tempus AI acquires Personalis for $1.5 billion to expand cancer MRD testing capabilities, targeting a $20 billion market with AI-driven precision oncology. The post Tempus AI strikes $1.5B deal for Personalis, betting big on AI-powered canc…
All coverage
Tempus AI to acquire cancer-monitoring firm Personalis for $1.5B
Tempus AI strikes $1.5B deal for Personalis, betting big on AI-powered cancer detection
Tempus AI acquires Personalis for $1.5 billion to expand cancer MRD testing capabilities, targeting a $20 billion market with AI-driven precision oncology. The post Tempus AI strikes $1.5B deal for Personalis, betting big on AI-powered canc…